Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (ALLPhi)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00905398
Recruitment Status : Terminated (The study was terminated due to excessive toxicity and low compliance to the protocol scheme.)
First Posted : May 20, 2009
Last Update Posted : July 9, 2015
Information provided by (Responsible Party):
Rony Schaffel, Universidade Federal do Rio de Janeiro

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : June 2012
  Estimated Study Completion Date : July 2015